Current News

	Search for:		in:

Target:

Full text

Title

Company name

Division:

Country:

From:

To:

Operation:		OR		AND
Search for:		partial		exact

Overview

Companies

Countries

Digilab BioVisioN GmbH closes cooperation agreement with Boehringer Ingelheim

06 Apr 2006 - Digilab BioVisioN GmbH announced closing of a cooperation contract with Boehringer Ingelheim Pharma GmbH & Co. KG. This is the first collaboration contract of the company that takes over commercial activities from BioVisioN AG within a reorganization process.

�
Within the project Digilab BioVisioN will analyze the quantitative peptide content of biological samples for the German pharmaceutical company. Using the patent-protected Peptidomics�-Technologies of Digilab BioVisioN, differences in peptide patterns are sought in order to identify new biomarkers. Further details of the project were not released.

�

Additional information

Boehringer Ingelheim Pharma GmbH & Co. KG
Ingelheim am Rhein, Germany

News

	10 Sep 2008 -	Orexo and Boehringer Ingelheim Extend Their Research Collaboration
	18 Jul 2008 -	Boehringer Ingelheim licenses drug targets from autoimmune collaboration with Galapagos
	28 May 2008 -	Boehringer Ingelheim completes $36 million investment in Laval for state-of-the-art research centre
�more news

Digilab BioVisioN GmbH
Hannover, Germany

Company

Buyer's Guide entry of Digilab BioVisioN GmbH

�

News

	08 Aug 2007 -	Digilab BioVisioN receives ISO 9001:2000 Certificate
	12 Jul 2007 -	Digilab Peptidomics receives United States Patent for Alzheimer's Disease Biomarkers
	08 Aug 2005 -	BioVisioN receives research grant within BioChancePLUS program
�more news